133 related articles for article (PubMed ID: 9421357)
1. Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1997 Dec; 74(6):609-13. PubMed ID: 9421357
[TBL] [Abstract][Full Text] [Related]
2. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
[TBL] [Abstract][Full Text] [Related]
3. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
[TBL] [Abstract][Full Text] [Related]
4. p53-HSP70 complexes in oral dysplasia and cancer: potential prognostic implications.
Kaur J; Srivastava A; Ralhan R
Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):45-9. PubMed ID: 8729618
[TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features.
Kaur J; Das SN; Srivastava A; Ralhan R
Oral Oncol; 1998 Mar; 34(2):93-8. PubMed ID: 9682770
[TBL] [Abstract][Full Text] [Related]
6. P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma.
Friedrich RE; Bartel-Friedrich S; Plambeck K; Bahlo M; Klapdor R
Anticancer Res; 1997; 17(4B):3183-4. PubMed ID: 9329632
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of 70-kDa heat shock-protein in human oral tumorigenesis.
Kaur J; Ralhan R
Int J Cancer; 1995 Dec; 63(6):774-9. PubMed ID: 8847132
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
[TBL] [Abstract][Full Text] [Related]
9. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
10. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.
Yamazaki Y; Chiba I; Ishikawa M; Satoh C; Notani K; Ohiro Y; Totsuka Y; Mizuno S; Kitagawa Y
Odontology; 2008 Jul; 96(1):32-7. PubMed ID: 18661202
[TBL] [Abstract][Full Text] [Related]
11. Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity.
Kaur J; Srivastava A; Ralhan R
Oral Oncol; 1998 Nov; 34(6):496-501. PubMed ID: 9930361
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum p53 antibodies in oral cancer.
Sainger RN; Shah MH; Desai AA; Shukla SN; Shah PM; Telang SD; Patel PS
Tumori; 2006; 92(2):134-9. PubMed ID: 16724693
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients.
Warnakulasuriya S; Soussi T; Maher R; Johnson N; Tavassoli M
J Pathol; 2000 Sep; 192(1):52-7. PubMed ID: 10951400
[TBL] [Abstract][Full Text] [Related]
14. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis.
Ralhan R; Swain RK; Agarwal S; Kaur J; Nath N; Sarkar G; Mathur M; Shukla NK
Int J Cancer; 1999 Feb; 84(1):80-5. PubMed ID: 9988237
[TBL] [Abstract][Full Text] [Related]
16. Serum p53 antibodies as early markers of lung cancer.
Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T
Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154
[TBL] [Abstract][Full Text] [Related]
17. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1998 Aug; 79(4):370-5. PubMed ID: 9699529
[TBL] [Abstract][Full Text] [Related]
19. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.
Neri M; Betta P; Marroni P; Filiberti R; Cafferata M; Mereu C; Ivaldi G; Montanaro F; Puntoni R; Paganuzzi M
Lung Cancer; 2003 Feb; 39(2):165-72. PubMed ID: 12581569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
